Get started
Author

Julie Arnold

Observed institution: Genocea (United States)
OpenAlex ID: A5032019897
Abstract 1762: InhibigensTM subvert otherwise-efficacious cancer vaccines and immunotherapies in conjunction with alterations in the tumor microenvironment
2021 · Hanna Starobinets, Victoria L. Devault, et al. · Cancer Research · 1
526 InhibigenTM-specific responses suppress anti-tumor immunity and promote tumor growth
2020 · Victoria DeVault, Tulin Dadali, et al. · Journal for ImmunoTherapy of Cancer · 1
Abstract 2088: ATLAS-identified Inhibigen-specific responses accelerate tumor growth in mouse melanoma and pancreatic cancer
2022 · Hanna S. Starobinets, Victoria L. DeVault, et al. · Cancer Research
753 InhibigenTM administration promotes aberrant T cell responses in cancer but may be beneficial for amelioration of autoimmune disease
2021 · Victoria DeVault, Hanna Starobinets, et al. · Journal for ImmunoTherapy of Cancer
PDF
Inhibigens™ drive pro-tumor responses and may act through non-classical inhibitory mechanisms
2021 · Victoria L DeVault, Hanna Starobinets, et al. · The Journal of Immunology
Works count: 5
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type